Exponential Clinical Outcomes (ECO24) was held online in May, 2024 and was created by Dr. Todd Watts and Dr. Jay Davidson who also created CellCore Biosciences.
I have posted Dr. Davidson’s removing parasites to fix Lyme & chronic illness, which I consider some of the best help for parasites out there. His wife battled Lyme/MSIDS so Davidson had to figure it all out to help her. I also posted Dr. Todd Watts’ ‘The Parasite Guy Podcast’ where he shares his own journey with parasites and Lyme disease.
The notes are in the link above and are provided by Scott Forsgren, FDN-P, better known as the BetterHealthGuy.
This is a wonderful resource for executive summaries of the various speakers who present on everything from foundation medicine, testing, why patients get worse, hormones, fasting, mold, unresolved trauma, ‘vaccine’ detox support, infertility, muscle testing, and much more. There’s certainly something for everyone in this seminar.
The U.S. Food and Drug Administration (FDA) is warning people to avoid using over-the-counter Cue Health’s COVID-19 tests due to an increased risk of giving false positive results.
In a warning letter, the FDA urges health care providers to also stop using Cue Health’s COVID-19 tests intended for patient care settings for the same reason.
The federal agency suggests that any consumers who may have Cue Health brand tests should dispose of those tests and consider using different COVID-19 tests that have been authorized by the FDA. (See link for article)
______________
**Comment**
COVID testing is abysmal, and has always been. Don’t do it. They ALL give false positives, just like Lyme testing gives false negatives, and people have tested positive for COVID one minute only be be negative the next minute, and don’t forget how the former President of Tanzania (RIP) punked the WHO by testing fruit, goats, sheep, even motor oil – with half coming back positive.
Our corrupt government ‘health’ agencies are all about monopolizing testing. They’ve been doing it for decades. It’s a big money maker for them and they want it all.
BREAKING: HHS Suspends Funding and Proposes Formal Debarment of EcoHealth Alliance, Cites Evidence from COVID Select Report
May 15, 2024
WASHINGTON — Today, Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup (R-Ohio) issued the following statement after the U.S. Department of Health and Human Services (HHS) accepted the Select Subcommittee’s recommendation to formally debar EcoHealth Alliance, Inc. (EcoHealth). HHS will immediately commence official debarment proceedings and implement a government-wide suspension of U.S. taxpayer funds to EcoHealth — including a hold on all active grants.
“EcoHealth Alliance and Dr. Peter Daszak should never again receive a single penny from the U.S. taxpayer. Only two weeks after the Select Subcommittee released an extensive report detailing EcoHealth’s wrongdoing and recommending the formal debarment of EcoHealth and its president, HHS has begun efforts to cut off all U.S. funding to this corrupt organization. EcoHealth facilitated gain-of-function research in Wuhan, China without proper oversight, willingly violated multiple requirements of its multimillion-dollar National Institutes of Health grant, and apparently made false statements to the NIH. These actions are wholly abhorrent, indefensible, and must be addressed with swift action. EcoHealth’s immediate funding suspension and future debarment is not only a victory for the U.S. taxpayer, but also for American national security and the safety of citizens worldwide.
“The Select Subcommittee’s investigation into EcoHealth and the origins of COVID-19 is far from over. Dr. Daszak and his team are still required to produce all outstanding documents and answer the Select Subcommittee’s questions, specifically related to Dr. Daszak’s potential dishonesty under oath. We will hold EcoHealth accountable for any waste, fraud, and abuse and are committed to uncovering any illegal activity, including lying to Congress, NIH, or the Inspector General,” said Chairman Wenstrup.
Read the Select Subcommittee’s report titled “An Evaluation of the Evidence Surrounding EcoHealth Alliance, Inc.’s Research Activities” here.
Read today’s letter from HHS to EcoHealth Alliance, Inc. here.
Dive into the complex world of Bartonella with Dr. Ed Breitschwerdt, a leading veterinary researcher. Unravel the challenges of diagnosing this elusive bacteria, from understanding its diverse transmission vectors to exploring advanced detection methods like digital PCR. Gain insights into the pathophysiology of chronic Bartonella infections and its potential neuropsychiatric manifestations through intriguing case studies. Discover the intricate interplay between acute and chronic phases, antibody production, and the prevalence of different strains that can impact test results. Don’t miss this opportunity to elevate your expertise in managing Bartonella and its intricate implications for human health.
01:18:03 Future Goals: Diagnostic Test and Vaccine
Learn more about my guest: Dr. Ed Breitschwerdt, DVM , DACVIM Learn more about Dr. Breitschwerdt and his work at NC State University- https://globalhealth.cvm.ncsu.edu/fac…
WOMAN DEVELOPS LYME DISEASE SYMPTOMS AFTER GIVING BIRTH
In their article, “An Unusual Case of Serologically Confirmed Post-Partum Lyme Disease Following an Asymptomatic Borrelia burgdorferi Infection Acquired during Pregnancy and Lacking Vertical Transmission in Utero,” Pavia et al. describe the case of a young woman who developed symptoms of Lyme disease immediately following the birth of her child. [1]
A 23-year-old woman, who lived in Brooklyn, NY, had visited her primary care doctor complaining of bilateral knee swelling and pain. Three days prior, she had delivered a healthy baby girl.
When the woman was 6 months pregnant, she experienced similar knee pain briefly but never sought treatment.
“Interestingly, except for a brief 2-day period where she experienced knee pain, she remained symptom-free for Lyme disease for the remainder of the pregnancy.”
During her pregnancy the woman had taken several trips to wooded areas in upstate New York.
She denied any known exposure to ticks or the development of any rash.
Testing for Lyme disease was positive by Western blot with several reactive bands including: 18, 23, 28, 33, 41,43, 58, 66, and 93 kDa.
The woman was treated successfully with a 3-week course of doxycycline.
Her newborn was symptom-free at birth and has never shown any of the usual signs or symptoms of active disease well into early childhood and beyond, the authors state.
According to the authors, “There was no evidence for congenital or perinatal transmission of this pathogen at any point pre-term or postnatally.”
Pavia CS, Plummer MM, Varantsova A. An Unusual Case of Serologically Confirmed Post-Partum Lyme Disease Following an Asymptomatic Borrelia burgdorferi Infection Acquired during Pregnancy and Lacking Vertical Transmission in Utero. Pathogens. 2024 Feb 20;13(3):186. doi: 10.3390/pathogens13030186. PMID: 38535530; PMCID: PMC10976031.
______________
**Comment**
This, of course, will be used ad nauseam to push the myth that congenital transmission is rare or doesn’t occur. FALSE! Further, it is widely known that the immune system often keeps the infection in check until a trigger sets it off.
Vector-borne infections may underlie some rheumatic diseases, particularly in people with joint effusions. This study aimed to compare serum and synovial fluid antibodies to B. burgdorferi and Bartonella spp. in patients with rheumatic diseases. This observational, cross-sectional study examined paired synovial fluid and serum specimens collected from 110 patients with joint effusion between October 2017 and January 2022. Testing for antibodies to B. burgdorferi (using CDC criteria) and Bartonella spp. via two indirect fluorescent antibody (IFA) assays was performed as part of routine patient care at the Institute for Specialized Medicine (San Diego, CA, USA). There were 30 participants (27%) with positive two-tier B. burgdorferi serology and 26 participants (24%) with IFA seroreactivity (≥1:256) to B. henselae and/or B. quintana. Both B. burgdorferi IgM and IgG were detected more frequently in synovial fluid than serum: 27% of patients were either IgM or IgG positive in synovial fluid, compared to 15.5% in serum (P = 0.048). Conversely, B. henselae and B. quintana antibodies were detected more frequently in serum than synovial fluid; overall only 2% of patients had positive IFA titers in synovial fluid, compared to 24% who had positive IFA titers in serum (P < 0.001). There were no significant associations between B. burgdorferi or Bartonella spp. seroreactivity with any of the clinical rheumatological diagnoses. This study provides preliminary support for the importance of synovial fluid antibody testing for documenting exposure to B. burgdorferi but not for documenting exposure to Bartonella spp.
IMPORTANCE This study focuses on diagnostic testing for two common vector-borne diseases in an affected patient population. In it, we provide data showing that antibodies to B. burgdorferi, but not Bartonella spp., are more commonly found in synovial fluid than serum of patients with joint effusion. Since Lyme arthritis is a common—and sometimes difficult to diagnose—rheumatic disease, improving diagnostic capabilities is of utmost importance. While our findings are certainly not definitive for changes to practice, they do suggest that synovial fluid could be a useful sample for the clinical diagnosis of Lyme disease, and future prospective studies evaluating this claim are warranted.
Madison Area Lyme Support Group 